GHK-Cu and Pal-GHK are built on the identical three amino acids, glycine, histidine and lysine, and everything that distinguishes them comes down to what is attached. One version carries a copper ion. The other carries a 16-carbon fatty acid. Those two attachments send the same tripeptide down two different research paths, one biological and one largely cosmetic, and the comparison is a compact lesson in how much a modification can matter.
The shared core: GHK
The tripeptide GHK was identified in human plasma in the 1970s by Loren Pickart, who noticed that a small plasma fraction changed the behaviour of aged liver tissue. GHK occurs naturally in plasma, saliva and urine, and its concentration in plasma declines substantially with age, an observation that has driven interest in it ever since.
GHK has a chemically notable property: an unusually high affinity for copper(II). The histidine at position 2 and the free amino terminus form a tight binding site, so in biological fluids GHK exists substantially as its copper complex. That complex is GHK-Cu. The copper is not decoration; several of the peptide's reported activities, including its roles in collagen synthesis signalling, wound remodelling and antioxidant enzyme support, are tied to its function as a copper-delivery vehicle. Pickart's group and others have also catalogued extensive gene-expression effects, summarised in his 2018 review with Margolina.
What palmitoylation does instead
Pal-GHK, also called palmitoyl tripeptide-1 and known from the cosmetic ingredient literature as part of Matrixyl-type blends, takes the same GHK sequence and attaches palmitic acid, a 16-carbon saturated fatty acid, to the N-terminus.
The purpose is delivery, not biology. A bare tripeptide is water-soluble and crosses the skin's lipid barrier poorly. The palmitoyl tail makes the molecule amphiphilic, dramatically improving its ability to partition into and through the stratum corneum in topical formulations. The trade-off is at the other end of the molecule: occupying the N-terminus removes half of the copper-binding site, so Pal-GHK is not meaningfully a copper carrier. It delivers the peptide signal, reported in the cosmetic literature as support for collagen and extracellular matrix production, without the copper chemistry.
That is the entire comparison in miniature. GHK-Cu is the tripeptide as a copper complex, active in the biology copper participates in. Pal-GHK is the tripeptide as a skin-penetrant signal, built for formulation.
Two literatures of different characters
The GHK-Cu literature is the deeper one, spanning wound-healing models, gene-expression profiling and decades of dermatological study, though it is fair to say much of it comes from a small circle of researchers and from models rather than large controlled human trials. Gorouhi and Maibach's review of topical peptides gives a sober framing of the human cosmetic evidence: promising, mechanistically plausible, and thinner than the marketing built on it.
The Pal-GHK literature is almost entirely cosmetic-science: formulation studies, instrumental measurements of skin parameters, and ingredient-combination trials, frequently industry-associated. It answers formulation questions well and biological questions barely. Anyone comparing the two compounds is therefore usually comparing a biology literature against a formulation literature, which is worth noticing before drawing conclusions from either.
Where each belongs in a catalogue
Because the copper complex is the biologically studied form, GHK-Cu is the version supplied across formats for research: the GHK-Cu vial for reconstitution work, GHK-Cu tablets for oral-format research, and the GHK-Cu nasal spray for intranasal work, with the format question itself covered in our comparison of GHK-Cu delivery formats. Pal-GHK appears mainly as a formulated cosmetic ingredient rather than a standalone research compound, and we profile it separately in our Pal-GHK article.
The copper family has one more frequently confused member, AHK-Cu, which swaps the glycine for alanine and carries its own hair-focused literature; that comparison lives in AHK-Cu vs GHK-Cu.
The takeaway
Same tripeptide, two attachments, two purposes. GHK-Cu binds copper and owns the biological research record, from wound models to gene expression. Pal-GHK trades the copper site for a fatty-acid tail that gets the peptide through skin, and owns the cosmetic formulation record. Neither is an upgrade of the other; they are the same three amino acids answering two different questions, and the attachment tells you which literature to read.
All products are intended for research use only. Not for human consumption. Must be 21 years of age or older to purchase.
References
1. Pickart, L., & Margolina, A. (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences, 19(7), 1987.
2. Pickart, L. (2008). The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition, 19(8), 969-988.
3. Gorouhi, F., & Maibach, H. I. (2009). Role of topical peptides in preventing or treating aged skin. International Journal of Cosmetic Science, 31(5), 327-345.
